CareDx, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CDNA | IMDX | PSNL | BLLN | NEO | RVTY | |
|---|---|---|---|---|---|---|
| Market cap | 4.51B | 86.72M | 1.69B | 5.37B | 2.22B | 17.79B |
| P/E (TTM) | 36.2 | — | — | 180.8 | — | 70.9 |
| Forward P/E | 54.4 | -3.3 | -16.3 | 76.7 | 54.5 | 26.9 |
| Price/book | 9.6 | -4.1 | 6.2 | 9.9 | 2.8 | 2.5 |
| Dividend yield | — | — | — | — | — | 0.18% |
| 1-year change | +435.21% | −58.86% | +105.61% | +1.39% | +61.36% | +76.60% |
| Today | −2.95% | −3.28% | +0.25% | +3.11% | +1.90% | −2.48% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All CDNA news ›Top Movers: CareDx and Regeneron Surge While Reddit and Intel Tumble on Volatile Friday
CareDx soared 22% and Regeneron jumped 13% on Friday, while Reddit cratered 29% and Intel shed nearly 29% in a volatile session. Top Movers: CareDx and Regeneron Surge While Reddit and Intel Tumble on Volatile Friday US equities saw sharp…
Midday Movers: CareDx Surges 23% as Intel and Reddit Crater on Friday
CareDx soars 23% while Intel and Reddit each crash nearly 30% in a volatile midday session on Friday, 30 October 2026. Midday Movers: CareDx Surges 23% as Intel and Reddit Crater on Friday US equities are seeing sharp swings at midday on…
Why CareDx Stock Soared Today
Shares of CareDx (CDNA +22.22%) rose more than 22% on Friday after the medical diagnostics provider reported impressive growth metrics. CareDx's revenue surged 39% year over year to $139 million in the third quarter. The gains were driven…
What CareDx (CDNA) Said on Its Q3 Earnings Call
Posted by Michael Walen on Oct 31st, 2026 CareDx (NASDAQ:CDNA) reported third-quarter 2026 revenue growth of 39% as testing volumes increased, driven by its transplant business and the addition of Specialty Oncology testing following the…
More from 1 other outlet
CareDx raises 2026 revenue outlook to $520M-$530M as it plans AlloHeme launch in Q1 2027
CareDx Q3 2026 earnings: revenue jumps 39%, guidance rises, and AlloHeme launch stays on track. Earnings Call Insights: CareDx (CDNA) Q3 2026 "We had another strong quarter of solid execution, extending our leadership in transplantation,…
CareDx, Inc. Raises Earnings Guidance for the Full Year 2026
CareDx, Inc. raised earnings guidance for the full year 2026. For the year, the company now expects revenue to be in the range of $520 million to $530 million, compared with its previously disclosed... Published on 10/29/2026 at 04:01 pm…
Transcript : CareDx, Inc., Q3 2026 Earnings Call, Oct 29, 2026
Presentation Operator MessageOperator Hello, everyone. Thank you for joining us, and welcome to the CareDx Q3 2026 Earnings Call. [Operator Instructions] I will now hand the conference over to Nina... Transcript : CareDx, Inc., Q3 2026…
CareDx (NASDAQ:CDNA) & SAB Biotherapeutics (NASDAQ:SABS) Head to Head Comparison
Posted by Michael Walen on Oct 31st, 2026 CareDx (NASDAQ:CDNA – Get Free Report) and SAB Biotherapeutics (NASDAQ:SABS – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two businesses…
Tranche Update on CareDx, Inc.'s Equity Buyback Plan announced on June 3, 2025.
From April 1, 2026 to June 30, 2026, the company has repurchased 569,569 shares, representing 1.11% for $12.23 million. With this, the company has completed the repurchase of 3,328,988 shares,... Published on 07/30/2026 at 04:05 pm EDT…
Scribe Therapeutics Inc. (NASDAQ:SCTX) Stock Has Consensus Price Target of $51.75
Posted by Defense World Staff on Oct 26th, 2026 Read Our Latest Analysis on SCTX Scribe Therapeutics is a biotechnology company focused on developing CRISPR-based genetic medicines. The company’s platform is designed to engineer CRISPR…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net10
- marketscreener.com8
- themarketsdaily.com5
- seekingalpha.com2
- biospace.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 30 articles, not a forecast.